These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1221423)

  • 1. [Mechanism of the side effects of rifadin and ethambutol].
    Firsova LP; Liuboshenko LA
    Probl Tuberk; 1975; (12):42-5. PubMed ID: 1221423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 5. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
    Barbu Z; Alexa M; Josefovics F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of rifadin and ethambutol in pulmonary tuberculosis with concomitant diseases].
    Pak FP; Kertselli IuS
    Probl Tuberk; 1976 May; (5):78-80. PubMed ID: 951414
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    J Indian Med Assoc; 1986 Dec; 84(12):376-8. PubMed ID: 3585015
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy of pulmonary tuberculosis using rifampicin and ethambutol].
    Haegi V
    Helv Med Acta Suppl; 1969; 49():81-7. PubMed ID: 5267584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Organizaton and effectiveness of controlled intermittent outpatient treatment with ethambutol and rifadin in fibro-carvernous pulmonary tuberculosis].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1975; (1):17-21. PubMed ID: 1144360
    [No Abstract]   [Full Text] [Related]  

  • 18. A national therapy project for drug resistant pulmonary tuberculosis.
    Øvreberg K; Bjartveit K
    Scand J Respir Dis; 1974; 55(4):218-28. PubMed ID: 4140569
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side effects in strictly supervised treatment with rifampicin and ethambutol].
    Năstase M; Năstase R; Brener E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):241-3. PubMed ID: 174182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.